|
|
||||||||
Department of Cellular Physiology, Institute of Nephrology, Niigata University School of Medicine, Niigata 951 - 8510, Japan
We examined the
effects of endothelin (ET) on the activity of matrix
metalloproteinase-2 (MMP-2) in cultured MCs. Addition of the
ETA receptor antagonists or neutralizing anti-endothelin antibody into MC cultures markedly augmented the secretion and activation of MMP-2. On the contrary, addition of the exogenous ET-1
into MC culture significantly inhibited the synthesis of MMP-2 in both
basal and cytokines (tumor necrosis factor-
and interferon-
) plus
lipopolysaccharide-stimulated conditions. Furthermore, pretreatment of
cells with exogenous ET-1 obviously prevented cytochalasin
D-elicited activation of MMP-2, an effect that was completely abolished by ETA receptor antagonist, FR139317.
In addition, ET-1 was found to be able to suppress the expression of
membrane type-1 MMP (MT1-MMP) and promote the conversion of tissue
inhibitor of matrix metalloproteinase-2 (TIMP-2) from cell associated
form to secreted form. The addition of recombinant TIMP-2 into the
culture abrogated dose-dependently the cytochalasin D-elicited activation of MMP-2. These results suggest that
ET is a potent inhibitor of MMP-2 secretion and activation in MCs. These novel findings may help us understand the subtle regulation of
the synthesis and activation of MMP-2 in MCs. It also provides us with
further insight into the pathophysiological mechanisms involving ET in
the regulation of matrix turnover in glomerulus.
endothelin receptor antagonist; tissue inhibitor of matrix metalloproteinase-2; zymography; cytochalasin D; cytokines
This article has been cited by other articles:
![]() |
T.-V. Do, J. C. Symowicz, D. M. Berman, L. A. Liotta, E. F. Petricoin III, M. S. Stack, and D. A. Fishman Lysophosphatidic Acid Down-Regulates Stress Fibers and Up-Regulates Pro-Matrix Metalloproteinase-2 Activation in Ovarian Cancer Cells Mol. Cancer Res., February 1, 2007; 5(2): 121 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Portik-Dobos, A. K. Harris, W. Song, J. Hutchinson, M. H. Johnson, J. D. Imig, D. M. Pollock, and A. Ergul Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R435 - R441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sorokin and D. E. Kohan Physiology and pathology of endothelin-1 in renal mesangium Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hubchak, C. E. Runyan, J. I. Kreisberg, and H. W. Schnaper Cytoskeletal Rearrangement and Signal Transduction in TGF-{beta}1-Stimulated Mesangial Cell Collagen Accumulation J. Am. Soc. Nephrol., August 1, 2003; 14(8): 1969 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yao, T. Morioka, B. Li, and T. Oite Coordination of Mesangial Cell Contraction by Gap Junction-Mediated Intercellular Ca2+ Wave J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2018 - 2026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |